Health company Essity stated on Wednesday that it has scaled up the production of its Tork-branded hand sanitizers capacity to meet the increased demand in Europe following the challenges, impact and focus of the COVID-19 pandemic on hand hygiene.
In the Q4 2020, the company will increase its supply capacity of hand sanitizer in Europe to enable the continued high growth of the existing range. Its Professional Hygiene business, under the leading global brand Tork, has seen a steep increase in demand for hand sanitizers in response to new hygiene regulations or customers' desire to provide an additional layer of safety where water and soap are not available.
Based on the research conducted on the company's behalf in July 2020, the hand hygiene is now an integral part of everyday routines and that 74% of people now consider hand hygiene to be more a part of their overall health routine than before the COVID-19 pandemic. About 69% of respondents find hand sanitizers a good complement to washing hands.
With an increase in the sanitizer capacity, the businesses and their employees and customers can offer consistent and reliable access to hand-hygiene products when handwashing is not readily available, concluded the company.
Genentech reports positive Phase II results for enicepatide in type 2 diabetes
Pharming reports positive Phase II data for leniolisib in primary immunodeficiencies
Insmed's ARIKAYCE sNDA granted priority review by FDA
Precigen announces FDA platform technology designation for AdenoVerse
Enhertu recommended for EU approval in early HER2-positive breast cancer
PureTech receives FDA Fast Track designation for LYT-200 in HR-MDS
CHMP recommends EU approval of Klygefa for generalised myasthenia gravis
Coiled Therapeutics completes enrolment in two AO-252 formulation cohorts
MaaT Pharma outlines potential Phase 3 development plan for MaaT013 after CHMP negative opinion
Kemp Proteins partners with NeuImmune to advance precision protein production
Bayer's Kerendia wins FDA approval for chronic kidney disease associated with type 1 diabetes